Today's tickers: MNKD, SKX, FXI, SBUX, VIX, ACOR, NFLX, AMR & UAUA
MNKD - Mannkind Corp. – Stop, hey, what's that sound? Everybody look what's going down…We reported bearish options activity on biopharmaceutical company, MannKind Corp., yesterday as investors shed call options and enacted pessimistic plays on the stock. Lo-and-behold, MannKind's shares plummeted today, falling 20% at times during the trading session to an intraday low of $7.52. News that its inhaled insulin drug, Afresa, could encounter delays at the U.S. Food and Drug Administration incensed investor uncertainty regarding the fate of MNKD's share price. Option implied volatility jumped 43.61% during the trading day from an intraday low of 116.96% up to the current reading of 167.97%. Frenzied bearish option traders populating the stock today are probably kicking themselves for not acting 24 hour earlier. One investor initiated a put spread today by purchasing 2,000 puts at the February 7.5 strike for an average premium of 1.79 apiece, spread against the sale of 2,000 puts at the lower February 5.0 strike for 64 cents premium each. The net cost of the transaction amounts to 1.15 per contract. Call selling is apparent at the February 10 strike where 1,300 calls sold for 1.21 each. Investors shed 1,200 calls at the higher February 12.5 strike to take in 73 cents premium per contract. Finally, a bearish risk reversal graced the May 2010 contract. It looks like one trader sold 1,250 calls at the May 10 strike for 2.15 apiece in order to partially finance the purchase of the same number of put options at the May 7.5 strike for 3.30 each. The net cost of the put options amounts to 1.15 per contract and yields profits to the downside beneath the breakeven point at $6.35. MNKD's shares must fall at least 15.5% from today's low of $7.52 before the investor responsible for the reversal play breaks even on the trade.
[Related -Sector Detector: Is There Still Enough Fuel In The Bulls’ Tank?]
[Related -The Secret “Buy” Signal That 99% Of Investors Fail To See]
SKX - Sketchers USA, Inc. – Fashion footwear manufacturer, Sketchers, received a vote of confidence by one option trader today who initiated a bullish risk reversal in the February contract. The investor implemented the optimistic strategy despite the 0.5% decline in SKX shares to $28.60. It looks like the trader sold 1,800 in-the-money puts at the February 30 strike for 3.00 apiece in order to finance the purchase of 1,800 out-of-the-money calls at the same strike for 2.00 each. The investor receives a net credit of 1.00 per contract on the transaction. The short sale of puts implies that the trader is obliged to have shares of the underlying stock put to him for an effective share price of $29.00 in the event that the puts land in-the-money by expiration.